TB Drug Headed Toward Accelerated Approval: Another Wrinkle for Priority Review Vouchers
This article was originally published in RPM Report
Executive Summary
A positive advisory committee for Janssen’s bedaquiline means the second priority review voucher is probably on its way. And it would be the first for an accelerated approval.